Oral News and Research

RSS

Preventive dental care could lead to lower overall dental expenses for older Americans

Older Americans could likely have lower overall dental expenses with preventive dental care and more routine dental visits, as indicated by a new study of public records of Medicare beneficiaries, says John Moeller, PhD, MA, research professor at the University of Maryland Dental School.

4 Feb 2011

CVT more common than previously thought, disproportionally affects pregnant women

A rare and often underreported form of stroke that involves veins instead of arteries is more common than previously thought, according to the American Heart Association's first scientific statement on diagnosing and managing cerebral venous thrombosis (CVT).

4 Feb 2011

USF Health sponsors conference on Parkinson's disease and multiple sclerosis

Some of the country's leading physicians and researchers in the fields of Parkinson's disease and multiple sclerosis will gather later this month to discuss the latest advances in the diagnosis and treatment of these neurological disorders.

3 Feb 2011

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

In light of an aging population and increasing chronic vascular disease, there is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors review of the vascular device market released today. Both the CVI and the thrombosis segments present significant opportunities for medical device innovators.

3 Feb 2011

Proper diagnosis and antibiotic treatment are the best way to prevent Lyme arthritis

Early, correct diagnosis is the best way to prevent the development of Lyme arthritis in individuals with the tick-borne illness, according to a paper published in the Journal of the American Academy of Orthopaedic Surgeons. In patients who do develop the condition, most cases can be treated successfully with antibiotics, the review found.

3 Feb 2011

NIH awards CMU $1.2 million grant to analyze ethical, policy problems linked with DNA ID practices

Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.

3 Feb 2011

New state scorecard finds geographic disparities in health insurance coverage for children

Two years after the reauthorization and expansion of the Children's Health Insurance Program, a new Commonwealth Fund state-by-state scorecard evaluating how the health care system is working for children finds that federal and state action on behalf of children has helped preserve, and even expand, health coverage for this group, despite the severe recession.

2 Feb 2011

New study evaluates ideal crown-to-root ratio for successful implant restoration

Dental implants are now a common way to replace a tooth. But a dentist must first determine that an implant restoration can be successful for a particular patient. As an indicator, dentists use the crown-to-root ratio—how much of the tooth extends above the jawbone and how much is in the bone. However, the ideal crown-to-implant ratio for the replacement tooth has yet to be determined.

2 Feb 2011

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "urged developed nations to help him wipe out polio 'once and for all' at an event to release his third annual letter [.pdf] Monday," Agence France-Presse reports.

2 Feb 2011

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

Harbor BioSciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced publication of newly discovered anti-inflammatory steroids naturally present in humans.

2 Feb 2011

FDA to inspect Lannett's manufacturing facility for review of Morphine Sulfate NDA

Lannett Company, Inc., a manufacturer of generic pharmaceuticals, today announced that it recently met with the U.S. Food and Drug Administration (FDA) to discuss the status of the company's New Drug Application (NDA) for Morphine Sulfate Oral Solution as well as other pending product applications.

2 Feb 2011

Quebec provides access to new treatment for women with postmenopausal osteoporosis

Today Quebec is providing access to a therapy in a new class of osteoporosis treatments. With Quebec being the first province to list Prolia on public and private drug plans, Canadians living with osteoporosis in the province of Quebec now have access to increased treatment options.

2 Feb 2011

Study finds link between oral health care and heart disease

During American Heart Month in February, United Concordia Dental, one of the nation's largest dental insurers, wants to remind adults that taking care of their teeth and gums is an important part of promoting heart health.

2 Feb 2011

Oncology experts to discuss latest developments in head and neck cancers

The European Society for Therapeutic Radiology and Oncology (ESTRO), the European Head and Neck Society (EHNS), and the European Society for Medical Oncology (ESMO) in collaboration with other European partners, have the pleasure of inviting you to report on the 3rd International Conference on innovative approaches In Head and Neck Oncology that will be held in Barcelona (Spain) on the 24th -26th February 2011.

1 Feb 2011

Loyola opens Comprehensive Diabetes Care Clinic in Hickory Hills

Untreated or poorly managed diabetes can cause severe health complications such as kidney failure, blindness, heart disease, stroke and nerve damage. To help diabetic patients more easily care for their condition, Loyola has opened the Comprehensive Diabetes Care Clinic at Loyola Center for Health at Hickory Hills.

1 Feb 2011

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

Florida-based biopharmaceutical company Oragenics, today announced its intention to commence a second phase 1 clinical trial of SMaRT Replacement Therapy.

31 Jan 2011

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Apricus Biosciences, today announced that its research and development team at its NexMed, USA, Inc. subsidiary is presenting data demonstrating the use of the Company's proprietary NexACT technology to improve less permeable or less soluable drugs, at the Controlled Release Society Product Development Forum for Poorly Soluble Drugs, being held January 27 to 29, 2011, in Miami, Florida.

29 Jan 2011

Oral News and Research

Preventive dental care could lead to lower overall dental expenses for older Americans

CVT more common than previously thought, disproportionally affects pregnant women

USF Health sponsors conference on Parkinson's disease and multiple sclerosis

Scientia Advisors: Unmet need for new medical technologies to treat CVI and blood clots

Proper diagnosis and antibiotic treatment are the best way to prevent Lyme arthritis

NIH awards CMU $1.2 million grant to analyze ethical, policy problems linked with DNA ID practices

New state scorecard finds geographic disparities in health insurance coverage for children

New study evaluates ideal crown-to-root ratio for successful implant restoration

Bill Gates' annual letter calls for focus on eradicating polio, governments to sustain foreign aid

Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids

FDA to inspect Lannett's manufacturing facility for review of Morphine Sulfate NDA

Quebec provides access to new treatment for women with postmenopausal osteoporosis

Study finds link between oral health care and heart disease

Oncology experts to discuss latest developments in head and neck cancers

Loyola opens Comprehensive Diabetes Care Clinic in Hickory Hills

Oragenics to commence second phase 1 clinical trial for SMaRT Replacement Therapy

NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs

Published paper suggests some orthodontists may expose young patients to unnecessary radiation

UK government, Bill & Melinda Gates Foundation to support efforts to stamp out polio

United Concordia helps provide free dental care to more than 8,000 people during 2010

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News